|
1
|
Guermazi A, Brice P, de Kerviler EE, Fermé
C, Hennequin C, Meignin V and Frija J: Extranodal Hodgkin disease:
Spectrum of disease. Radiographics. 21:161–179. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zucca E: Extranodal lymphoma: A
reappraisal. Ann Oncol. 19 Suppl 4:iv77–iv80. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chan KW, Rosen G, Miller DR and Tan CT:
Hodgkin's diseases in adolescents presenting as a primary bone
lesion. A report of four cases and review of literature. Am J
Pediatr Hematol Oncol. 4:11–17. 1982.PubMed/NCBI
|
|
4
|
Biswas A, Puri T, Goyal S, Haresh KP,
Gupta R, Julka PK and Rath GK: Osseous Hodgkin's lymphoma-review of
literature and report of an unusual case presenting as a large
ulcerofungating sternal mass. Bone. 43:636–640. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
The International Non-Hodgkin's Lymphoma
Prognostic Factors Project: A predictive model for aggressive
non-Hodgkin's lymphoma. N Engl J Med. 329:987–994. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern Cooperative Oncology Group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
National Comprehensive Cancer and Network
(NCCN), . NCCN Guidelines for Patients®Version 2016
Hodgkin Lymphoma. NCCN; Fort Washington, PA: 2016
|
|
8
|
Ostrowski ML, Inwards CY, Strickler JG,
Witzig TE, Wenger DE and Unni KK: Osseous Hodgkin disease. Cancer.
85:1166–1178. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Toussirot E, Gallinet E, Augé B, Voillat L
and Wendling D: Anterior chest wall malignancies. A review of ten
cases. Rev Rhum Engl Ed. 65:397–405. 1998.PubMed/NCBI
|
|
10
|
Franczyk J, Samuels T, Rubenstein J,
Srigley J and Morava-Protzner I: Skeletal lymphoma. Can Assoc
Radiol J. 40:75–79. 1989.PubMed/NCBI
|
|
11
|
Meher-Homji DR, De Souza LJ, Mohanty B and
Culcuttawalla TF: Unusual sternal mass in Hodgkin's disease. A case
report. J Bone Joint Surg Am. 54:402–404. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eustace S, O'Regan R, Graham D and Carney
D: Primary multifocal skeletal Hodgkin's disease confined to bone.
Skeletal Radiol. 24:61–63. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fried G, Ben Arieh Y, Haim N, Dale J and
Stein M: Primary Hodgkin's disease of the bone. Med Pediatr Oncol.
24:204–207. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Citow JS, Rini B, Wollmann R and Macdonald
RL: Isolated, primary extranodal Hodgkin's disease of the spine:
Case report. Neurosurgery. 49:453–457. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gebert C, Hardes J, Ahrens H, Buerger H,
Winkelmann W and Gosheger G: Primary multifocal osseous Hodgkin
disease: A case report and review of the literature. J Cancer Res
Clin Oncol. 131:163–168. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Langley CR, Garrett SJ, Urand J, Kohler J
and Clarke NM: Primary multifocal osseous Hodgkin's lymphoma. World
J Surg Oncol. 6:342008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chandra D, Ewton A and Baker K: Hodgkin's
disease presenting with osseous involvement. Am J Hematol.
81:550–551. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Y, Wang XB, Tian XY, Li B and Li Z:
Unusual primary osseous Hodgkin lymphoma in rib with associated
soft tissue mass: A case report and review of literature. Diagn
Pathol. 7:642012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Binesh F, Mirjalili MR, Akhavan A and
Navabii H: Primary bony Hodgkin's lymphoma. BMJ Case Rep. 2012:pii:
bcr01201257142012. View Article : Google Scholar
|
|
20
|
Dühmke E, Franklin J, Pfreundschuh M,
Sehlen S, Willich N, Rühl U, Müller RP, Lukas P, Atzinger A, Paulus
U, et al: Low-dose radiation is sufficient for the noninvolved
extended-field treatment in favorable early-stage Hodgkin's
disease: Long-term results of a randomized trial of radiotherapy
alone. J Clin Oncol. 19:2905–2914. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gustavsson A, Osterman B and
Cavallin-Ståhl E: A systematic overview of radiation therapy
effects in Hodgkin's lymphoma. Acta Oncol. 42:589–604. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Newcomer LN, Silverstein MB, Cadman EC,
Farber LR, Bertino JR and Prosnitz LR: Bone involvement in
Hodgkin's disease. Cancer. 49:338–342. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dürr HR, Müller PE, Hiller E, Maier M,
Baur A, Jansson V and Refior HJ: Malignant lymphoma of bone. Arch
Orthop Trauma Surg. 122:10–16. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Borg MF, Chowdhury AD, Bhoopal S and
Benjamin CS: Bone involvement in Hodgkin's disease. Australas
Radiol. 37:63–66. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gustavsson A, Osterman B and
Cavallin-Ståhl E: A systematic overview of radiation therapy
effects in non-Hodgkin's lymphoma. Acta Oncol. 42:605–619. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mendenhall NP, Jones JJ, Kramer BS, Hudson
TM, Carter RL, Enneking WF, Marcus RB Jr and Million RR: The
management of primary lymphoma of bone. Radiother Oncol. 9:137–145.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Feltl D, Marková J and Kozák T: Skeletal
involvement in Hodgkin's lymphoma-personal experience. Vnitr Lek.
50:134–138. 2004.(In Czech). PubMed/NCBI
|
|
28
|
Israel O, Mekel M, Bar-Shalom R, Epelbaum
R, Hermony N, Haim N, Dann EJ, Frenkel A, Ben-Arush M and Gaitini
D: Bone lymphoma: 67Ga scintigraphy and CT for prediction of
outcome after treatment. J Nucl Med. 43:1295–1303. 2002.PubMed/NCBI
|
|
29
|
Dosoretz DE, Raymond AK, Murphy GF, Doppke
KP, Schiller AL, Wang CC and Suit HD: Primary lymphoma of bone: The
relationship of morphologic diversity to clinical behavior. Cancer.
50:1009–1014. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Carbone PP, Kaplan HS, Musshoff K,
Smithers DW and Tubiana M: Report of the committee on Hodgkin's
disease staging classification. Cancer Res. 31:1860–1861.
1971.PubMed/NCBI
|
|
31
|
Parker BR, Marglin S and Castellino RA:
Skeletal manifestations of leukemia, Hodgkin disease, and
non-Hodgkin lymphoma. Semin Roentgenol. 15:302–315. 1980.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pear BL: Skeletal manifestations of the
lymphomas and leukemias. Semin Roentgenol. 9:229–240. 1974.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Moog F, Kotzerke J and Reske SN: FDG PET
can replace bone scintigraphy in primary staging of malignant
lymphoma. J Nucl Med. 40:1407–1413. 1999.PubMed/NCBI
|
|
34
|
Seam P, Juweid ME and Cheson BD: The role
of FDG-PET scans in patients with lymphoma. Blood. 110:3507–3516.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Isasi CR, Lu P and Blaufox MD: A
metaanalysis of 18F-2-deoxy-2-fluoro-D-glucose positron emission
tomography in the staging and restaging of patients with lymphoma.
Cancer. 104:1066–1074. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Juweid ME: Utility of positron emission
tomography (PET) scanning in managing patients with Hodgkin
lymphoma. Hematology Am Soc Hematol Educ Program 259–265. 510–511.
2006.
|
|
37
|
Gallamini A, Rigacci L, Merli F, Nassi L,
Bosi A, Capodanno I, Luminari S, Vitolo U, Sancetta R, Iannitto E,
et al: The predictive value of positron emission tomography
scanning performed after two courses of standard therapy on
treatment outcome in advanced stage Hodgkin's disease.
Haematologica. 91:475–481. 2006.PubMed/NCBI
|
|
38
|
Gallamini A, Hutchings M, Avigdor A and
Polliack A: Early interim PET scan in Hodgkin lymphoma: Where do we
stand? Leuk Lymphoma. 49:659–662. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Terasawa T, Lau J, Bardet S, Couturier O,
Hotta T, Hutchings M, Nihashi T and Nagai H:
Fluorine-18-fluorodeoxyglucose positron emission tomography for
interim response assessment of advanced-stage Hodgkin's lymphoma
and diffuse large B-cell lymphoma: A systematic review. J Clin
Oncol. 27:1906–1914. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gallamini A, Hutchings M, Rigacci L,
Specht L, Merli F, Hansen M, Patti C, Loft A, Di Raimondo F,
D'Amore F, et al: Early interim 2-[18F]fluoro-2-deoxy-D-glucose
positron emission tomography is prognostically superior to
international prognostic score in advanced-stage Hodgkin's
lymphoma: A report from a joint Italian-Danish study. J Clin Oncol.
25:3746–3752. 2007. View Article : Google Scholar : PubMed/NCBI
|
